Codexis Inc (CDXS) - Total Liabilities

Latest as of September 2025: $85.42 Million USD

Based on the latest financial reports, Codexis Inc (CDXS) has total liabilities worth $85.42 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Codexis Inc - Total Liabilities Trend (2006–2024)

This chart illustrates how Codexis Inc's total liabilities have evolved over time, based on quarterly financial data. See Codexis Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Codexis Inc Competitors by Total Liabilities

The table below lists competitors of Codexis Inc ranked by their total liabilities.

Company Country Total Liabilities
M.C.S. Steel Public Company Limited
BK:MCS
Thailand ฿1.70 Billion
HORNG SHIUE HOLDING Co Ltd
TW:2243
Taiwan NT$2.54 Billion
Indústrias Romi S.A
SA:ROMI3
Brazil R$1.35 Billion
Supercomnet Technologies Bhd
KLSE:0001
Malaysia RM21.42 Million
PYRUM INNOV.AG NA O.N.
F:PYR
Germany €42.95 Million
Eidesvik Offshore ASA
OL:EIOF
Norway Nkr2.07 Billion
Keyrus SA
PA:ALKEY
France €264.99 Million
Uniquest
KO:077500
Korea ₩264.30 Billion

Liability Composition Analysis (2006–2024)

This chart breaks down Codexis Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Codexis Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.12 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.69 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Codexis Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Codexis Inc (2006–2024)

The table below shows the annual total liabilities of Codexis Inc from 2006 to 2024.

Year Total Liabilities Change
2024-12-31 $82.08 Million +64.35%
2023-12-31 $49.95 Million -52.70%
2022-12-31 $105.60 Million +28.79%
2021-12-31 $81.99 Million +59.07%
2020-12-31 $51.54 Million +18.34%
2019-12-31 $43.56 Million +98.19%
2018-12-31 $21.98 Million -24.42%
2017-12-31 $29.08 Million +75.71%
2016-12-31 $16.55 Million -23.98%
2015-12-31 $21.77 Million -0.20%
2014-12-31 $21.81 Million +25.66%
2013-12-31 $17.36 Million -19.36%
2012-12-31 $21.52 Million -35.23%
2011-12-31 $33.23 Million -2.08%
2010-12-31 $33.94 Million -45.44%
2009-12-31 $62.20 Million -68.90%
2008-12-31 $200.01 Million -0.50%
2007-12-31 $201.01 Million +102.17%
2006-12-31 $99.42 Million --

About Codexis Inc

NASDAQ:CDXS USA Biotechnology
Market Cap
$232.13 Million
Market Cap Rank
#18814 Global
#4299 in USA
Share Price
$2.57
Change (1 day)
+3.63%
52-Week Range
$0.98 - $3.33
All Time High
$41.78
About

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the … Read more